Prostate-specific membrane antigen PET/CT greatly improves the detection of prostate cancer metastases but is not prostate cancer specific, and a holistic review of lesion location, uptake intensity, imaging features, and clinical context is essential for accurate differentiation between true prostate cancer metastases and false-positive results.
Alavi et al. (Thu,) studied this question.